Measles outbreaks in the US are costing millions and signaling deeper public health failures. A 2018-2019 outbreak in Washington state with just 72 cases cost US$3.2 million in public health response, medical expenses, and lost productivity. Studies show that containing measles outbreaks can cost tens of thousands of dollars per case, making elimination economically beneficial.

Beyond the immediate costs, measles serves as a warning sign for how well America controls other infectious diseases. The same public health measures that stop measles—vaccination, contact tracing, isolation—are needed for diseases like whooping cough, which surged in 2024-2025. Declining MMR vaccination rates reveal eroding public trust in vaccines and government health agencies.

The Common Health Coalition warns that a sustained 1 percent drop in MMR coverage would cost the US billions across healthcare systems and the economy. With less than half of Americans trusting the CDC for reliable vaccine information, experts warn these cracks in public health infrastructure will complicate responses to future disease threats, whether outbreaks, pandemics, or biological attacks.